[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA18694A1 - Nouveaux derives de piperidinyl alkyl-quinazoline - Google Patents

Nouveaux derives de piperidinyl alkyl-quinazoline

Info

Publication number
MA18694A1
MA18694A1 MA18891A MA18891A MA18694A1 MA 18694 A1 MA18694 A1 MA 18694A1 MA 18891 A MA18891 A MA 18891A MA 18891 A MA18891 A MA 18891A MA 18694 A1 MA18694 A1 MA 18694A1
Authority
MA
Morocco
Prior art keywords
alkyl
group
aryl
independently selected
substituents
Prior art date
Application number
MA18891A
Other languages
English (en)
Inventor
Vandenberk Jean
Edmond Josephine Kennis Ludo
Josef Maria Theresia Va Marcel
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26669096&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA18694(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA18694A1 publication Critical patent/MA18694A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
MA18891A 1979-01-08 1980-01-04 Nouveaux derives de piperidinyl alkyl-quinazoline MA18694A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US149379A 1979-01-08 1979-01-08
US06/084,272 US4335127A (en) 1979-01-08 1979-10-12 Piperidinylalkyl quinazoline compounds, composition and method of use

Publications (1)

Publication Number Publication Date
MA18694A1 true MA18694A1 (fr) 1980-10-01

Family

ID=26669096

Family Applications (1)

Application Number Title Priority Date Filing Date
MA18891A MA18694A1 (fr) 1979-01-08 1980-01-04 Nouveaux derives de piperidinyl alkyl-quinazoline

Country Status (32)

Country Link
US (1) US4335127A (fr)
EP (1) EP0013612B1 (fr)
JP (1) JPS55105679A (fr)
KR (3) KR850000684B1 (fr)
AT (1) ATE5258T1 (fr)
AU (1) AU536175B2 (fr)
CA (1) CA1132557A (fr)
CS (1) CS223977B2 (fr)
CY (1) CY1252A (fr)
DE (1) DE3065489D1 (fr)
DK (1) DK170669B1 (fr)
ES (1) ES8101586A1 (fr)
FI (1) FI66609C (fr)
GR (1) GR67304B (fr)
HK (1) HK76284A (fr)
HU (1) HU184222B (fr)
IE (1) IE49351B1 (fr)
IL (1) IL59084A (fr)
LU (1) LU88219I2 (fr)
MA (1) MA18694A1 (fr)
MY (1) MY8700555A (fr)
NL (1) NL930018I2 (fr)
NO (1) NO155243C (fr)
NZ (1) NZ192551A (fr)
PH (1) PH17114A (fr)
PL (1) PL125789B1 (fr)
PT (1) PT70662A (fr)
RO (1) RO79148A (fr)
SG (1) SG48684G (fr)
SU (1) SU1041034A3 (fr)
YU (1) YU42957B (fr)
ZA (1) ZA8082B (fr)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA806501B (en) * 1979-10-27 1981-10-28 Richardson Merrell Inc 4-(4-alkyl-aroyl-1-piperidino)butyrophenone antipsychotic agents
CA1183847A (fr) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide; derives
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
ZA841728B (en) * 1983-03-09 1984-11-28 Ciba Geigy Ag Novel carboxamides
DK159420C (da) * 1983-03-09 1991-03-11 Ciba Geigy Ag N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater
JPS608274A (ja) * 1983-06-27 1985-01-17 Fujisawa Pharmaceut Co Ltd 新規キナゾリノン誘導体およびその製造法・並びに抗アレルギ−剤
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
CS247557B1 (en) * 1984-04-06 1987-01-15 Ludmila Fisnerova Esters of 3-(2-hydroxyethyl)-4(3h)-quinazolinone
EP0177078A1 (fr) * 1984-09-12 1986-04-09 Duphar International Research B.V Dérivés d'amines tertiaires spasmolytiques et méthodes pour leur préparation
US4634769A (en) * 1984-09-25 1987-01-06 Ortho Pharmaceutical Corporation Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts
US4665075A (en) * 1984-12-05 1987-05-12 Janssen Pharmaceutica N.V. Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
CA1246074A (fr) * 1984-12-05 1988-12-06 Albertus H.M.T. Van Heertum Derives de substitution hydroxyles ou amines de (piperidinylalcoyl)quinazolines
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
US4710502A (en) * 1985-11-04 1987-12-01 American Cyanamid Company 3-heteroarylalkyl-4-quinazolinones
US4753944A (en) * 1985-11-04 1988-06-28 American Cyanamid Company Pharmaceutical methods of using 3-heteroarylalkyl-4-quinazolinones
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
ES2094718T3 (es) * 1986-09-22 1997-02-01 Janssen Pharmaceutica Nv Antagonistas de la serotonine para el tratamiento de heridas.
US4874766A (en) * 1986-09-22 1989-10-17 Janssen Pharmaceutica N.V. Method of promoting wound-healing
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
JPH0434361Y2 (fr) * 1986-12-25 1992-08-17
DE3738844A1 (de) * 1987-11-16 1989-05-24 Merck Patent Gmbh Analgetikum
ES2087072T3 (es) * 1988-03-28 1996-07-16 Janssen Pharmaceutica Nv Agentes para conservar o restablecer la salud de la piel.
IL90879A0 (en) * 1988-09-02 1990-02-09 Janssen Pharmaceutica Nv 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
CA1340821C (fr) * 1988-10-06 1999-11-16 Nobuyuki Fukazawa Composes heterocycliques, ainsi que des adjuvants de produits anti-cancereux les comprenant
FR2644786B1 (fr) * 1989-03-21 1993-12-31 Adir Cie Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JP2744634B2 (ja) * 1989-04-14 1998-04-28 三菱重工業株式会社 ゴミ焼却装置
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5561128A (en) * 1989-05-19 1996-10-01 Hoechst-Roussel Pharmaceuticals, Inc. N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
IE913473A1 (en) * 1990-10-15 1992-04-22 Fujisawa Pharmaceutical Co Quinazoline derivatives and their preparation
US5158953A (en) * 1991-08-13 1992-10-27 National Science Council 2-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-ones (thiones), the preparation and use thereof
DE4138756A1 (de) * 1991-11-26 1993-05-27 Troponwerke Gmbh & Co Kg Kombination mit neuroprotektiver wirkung
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
GB9202915D0 (en) * 1992-02-12 1992-03-25 Wellcome Found Chemical compounds
ATE206119T1 (de) * 1992-02-13 2001-10-15 Merrell Pharma Inc Thiacyclische piperidinylderivate
FR2696744B1 (fr) * 1992-10-12 1994-12-30 Logeais Labor Jacques Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
DE69415391T2 (de) * 1993-05-26 1999-08-26 Sumitomo Pharmaceuticals Co. Chinazolinonderivate
SI0729357T1 (en) 1993-11-19 2005-06-30 Janssen Pharmaceutica N.V. Microencapsulated 1,2-benzazoles
EP0661266A1 (fr) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Composés cycliques aminés substitués comme 5HT2 antagonistes
US6184377B1 (en) 1997-12-15 2001-02-06 Sepracor Inc. Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
ATE302199T1 (de) * 1998-10-16 2005-09-15 Sumitomo Pharma Quinalozinon-derivate
GB9903784D0 (en) * 1999-02-18 1999-04-14 Lilly Co Eli Pharmaceutical compounds
KR20010108394A (ko) 1999-03-26 2001-12-07 다비드 에 질레스 신규 화합물
US6476041B1 (en) * 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
GB2362381A (en) * 2000-05-18 2001-11-21 Lilly Co Eli Pharmaceutically active indolyl-piperidines
US6844338B2 (en) 2000-05-18 2005-01-18 Eli Lilly And Company Piperidyindoles as serotonin receptor ligands
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) * 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
DE10101324C1 (de) * 2001-01-13 2001-12-13 Ibfb Gmbh Privates Inst Fuer B 1-Dimercaptoalkylchinazolin-2,4-(1H,3H)-dione als Matrix-Metalloproteinase(MMP)-Inhibitoren
GB0117899D0 (en) * 2001-07-23 2001-09-12 Astrazeneca Ab Chemical compounds
SE0102809D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab Novel compounds
GB0126433D0 (en) * 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
TW200813014A (en) * 2002-03-28 2008-03-16 Astrazeneca Ab Quinazoline derivatives
US6924285B2 (en) * 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
CN100390146C (zh) * 2002-11-13 2008-05-28 斯索恩有限公司 制备利培酮的方法和用于该方法的中间体
GB0309009D0 (en) * 2003-04-22 2003-05-28 Astrazeneca Ab Quinazoline derivatives
WO2004094415A1 (fr) * 2003-04-22 2004-11-04 Synthon B.V. Monochlorhydrates de risperidone
GB0309850D0 (en) * 2003-04-30 2003-06-04 Astrazeneca Ab Quinazoline derivatives
US20070032508A1 (en) * 2003-09-16 2007-02-08 Bradbury Robert H Quinazoline derivatives as tyrosine kinase inhibitors
GB0321648D0 (en) * 2003-09-16 2003-10-15 Astrazeneca Ab Quinazoline derivatives
WO2005026156A1 (fr) * 2003-09-16 2005-03-24 Astrazeneca Ab Derives de quinazoline
CA2538884C (fr) * 2003-09-16 2010-09-21 Astrazeneca Ab Derives de quinazoline utilises comme inhibiteurs de la tyrosine kinase
CN1882569B (zh) * 2003-09-19 2010-09-29 阿斯利康(瑞典)有限公司 喹唑啉衍生物
US20070037837A1 (en) * 2003-09-19 2007-02-15 Hennequin Laurent Francois A Quinazoline derivatives
AU2004276055A1 (en) * 2003-09-25 2005-04-07 Astrazeneca Ab Quinazoline derivatives
GB0322409D0 (en) * 2003-09-25 2003-10-29 Astrazeneca Ab Quinazoline derivatives
WO2005040129A2 (fr) * 2003-10-24 2005-05-06 F. Hoffmann-La Roche Ag Antagonistes du recepteur ccr3
GB0326459D0 (en) * 2003-11-13 2003-12-17 Astrazeneca Ab Quinazoline derivatives
BRPI0416206A (pt) 2003-11-20 2006-12-26 Janssen Pharmaceutica Nv 2-quinolinonas e 2-quinoxalinonas substituìdas por 6-alquenila e 6-fenilalquila como inibidores de polimerase de poli(adp-ribose)
UA91002C2 (ru) * 2003-11-20 2010-06-25 Янссен Фармацевтика Н.В. 7-фенилалкилзамещенные 2-хинолиноны и 2-хиноксалиноны как ингибиторы поле(адф-рибоза)полимеразы
EA010488B1 (ru) * 2003-12-05 2008-10-30 Янссен Фармацевтика Н.В. 6-замещённые 2-хинолиноны и 2-хиноксалиноны как ингибиторы поли (адф-рибоза) полимеразы
US7632840B2 (en) * 2004-02-03 2009-12-15 Astrazeneca Ab Quinazoline compounds for the treatment of hyperproliferative disorders
EP1756088A1 (fr) * 2004-06-04 2007-02-28 AstraZeneca AB Derives de quinazoline utilises comme tyrosine kinases du recepteur erbb
NZ551840A (en) * 2004-06-30 2009-07-31 Janssen Pharmaceutica Nv Substituted 2-alkyl quinzolinone derivatives as PARP inhibitors
US8080557B2 (en) 2004-06-30 2011-12-20 Janssen Pharmaceutica, Nv Quinazolinedione derivatives as PARP inhibitors
CA2569824C (fr) * 2004-06-30 2013-03-19 Janssen Pharmaceutica N.V. Derives de phtalazine utilises comme inhibiteurs de parp
ATE501148T1 (de) 2004-12-14 2011-03-15 Astrazeneca Ab Pyrazolopyrimidinverbindungen als antitumormittel
CA2599210A1 (fr) * 2005-02-26 2006-08-31 Astrazeneca Ab Derives de quinazoline servant d'inhibiteurs de tyrosine kinase
GB0504474D0 (en) * 2005-03-04 2005-04-13 Astrazeneca Ab Chemical compounds
GB0508717D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Chemical compounds
GB0508715D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Chemical compounds
WO2007034144A1 (fr) * 2005-09-20 2007-03-29 Astrazeneca Ab Composes de 4- (ih-indazol-s-yl-amino)-quinazoline utilises comme inhibiteurs des tyrosines kinases erbb associees au recepteur pour traiter le cancer
US20090239861A1 (en) * 2005-09-20 2009-09-24 Robert Hugh Bradbury Quinazoline derivatives as anticancer agents
JP2009517450A (ja) * 2005-12-02 2009-04-30 アストラゼネカ アクチボラグ チロシンキナーゼ阻害薬としての４−アニリノ置換キナゾリン誘導体
CN101321739A (zh) * 2005-12-02 2008-12-10 阿斯利康(瑞典)有限公司 用作erbB酪氨酸激酶抑制剂的喹唑啉衍生物
EP1921070A1 (fr) * 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG heterocycles bicycliques, medicaments á base de ces composes, leur usage et procédé pour leur preparation
KR20090116782A (ko) * 2007-02-06 2009-11-11 베링거 인겔하임 인터내셔날 게엠베하 바이사이클릭 헤테로사이클, 당해 화합물을 함유하는 약물, 이의 용도 및 이의 제조방법
JP5545955B2 (ja) * 2007-03-08 2014-07-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｐａｒｐおよびｔａｎｋ阻害剤としてのキノリノン誘導体
ES2448870T3 (es) * 2007-10-26 2014-03-17 Janssen Pharmaceutica, N.V. Derivados de quinolina como inhibidores de PARP
RS52573B (en) * 2008-02-07 2013-04-30 Boehringer Ingelheim International Gmbh SPIROCYCLIC HETEROCYCLES, THE MEDICINAL PRODUCTS CONTAINING THIS UNIT, THEIR APPLICATION AND THE PROCEDURE FOR THEIR MANUFACTURING
CA2716726C (fr) 2008-03-27 2017-01-24 Janssen Pharmaceutica Nv Tetrahydrophenanthridinones et tetrahydrocyclopentaquinolinones comme inhibiteurs de la polymerisation de la tubuline et de parp
WO2009118384A1 (fr) * 2008-03-27 2009-10-01 Janssen Pharmaceutica Nv Dérivés de quinazolinone comme inhibiteurs de la polymérisation de la tubuline
WO2009138781A1 (fr) * 2008-05-13 2009-11-19 Astrazeneca Ab Sel de fumarate de 4-(3-chloro-2-fluoroanilino)-7-méthoxy-6-{[1-(n-méthylcarbamoylméthyl)pipéridin-4-yl]oxy}quinazoline
EP2313397B1 (fr) * 2008-08-08 2016-04-20 Boehringer Ingelheim International GmbH Hétérocycles substitués par cyclohexyloxy, médicament contenant ces liaisons, leur utilisation et leur procédé de fabrication
US8440693B2 (en) 2009-12-22 2013-05-14 Novartis Ag Substituted isoquinolinones and quinazolinones
CU24130B1 (es) 2009-12-22 2015-09-29 Novartis Ag Isoquinolinonas y quinazolinonas sustituidas
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
JP6171003B2 (ja) 2012-05-24 2017-07-26 ノバルティス アーゲー ピロロピロリジノン化合物
WO2014115077A1 (fr) 2013-01-22 2014-07-31 Novartis Ag Composés de purinone substitués
EP2948453B1 (fr) 2013-01-22 2017-08-02 Novartis AG Composés pyrazolo[3,4-d]pyrimidinone utilisés en tant qu'inhibiteurs de l'interaction p53/mdm2
US9890166B2 (en) 2013-05-27 2018-02-13 Novartis Ag Imidazopyrrolidine derivatives and their use in the treatment of disease
US9624247B2 (en) 2013-05-28 2017-04-18 Novartis Ag Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
PL3004112T3 (pl) 2013-05-28 2018-02-28 Novartis Ag Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby
CN105916857B (zh) 2013-11-21 2018-06-22 诺华股份有限公司 吡咯并吡咯酮衍生物及其作为bet抑制剂的用途
WO2017003724A1 (fr) 2015-07-01 2017-01-05 Crinetics Pharmaceuticals, Inc. Modulateurs de somatostatine et leurs utilisations
CN106866625B (zh) * 2017-01-17 2019-12-13 上海鼎雅药物化学科技有限公司 酮色林的制备方法
WO2019023278A1 (fr) 2017-07-25 2019-01-31 Crinetics Pharmaceuticals, Inc. Modulateurs de la somatostatine et utilisations de ces derniers
CN109157507A (zh) * 2018-09-14 2019-01-08 上海禾丰制药有限公司 酒石酸酮色林注射液及其制备方法
CN112142760A (zh) * 2020-10-20 2020-12-29 江苏法安德医药科技有限公司 一种酮色林中间体以及酮色林的制备方法
WO2023133524A1 (fr) * 2022-01-06 2023-07-13 Terran Biosciences, Inc. Procédé de synthèse de la kétansérine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322766A (en) * 1964-11-13 1967-05-30 Shulton Inc 3-beta-(4-pyridyl) ethyl-2, 3-dihydro-4(1h)-quinazolinones
US3635976A (en) * 1967-12-20 1972-01-18 Pennwalt Corp 1 - heterocyclic alkyl-1 2 3 4-tetrahydroquinazolinones and analgesic intermediates thereof
US4096144A (en) * 1970-12-08 1978-06-20 Sumitomo Chemical Company, Limited Process for preparing quinazolinone derivatives and their 2-(N-mono-substituted amino)-phenyl ketone intermediate derivatives
US4099002A (en) * 1970-12-23 1978-07-04 Sumitomo Chemical Company, Limited Quinazolinone derivatives and a process for production thereof
US4146717A (en) * 1972-04-07 1979-03-27 Sumitomo Chemical Company, Limited Nitroquinazolinone compounds having antiviral properties
US4035369A (en) * 1975-10-08 1977-07-12 Janssen Pharmaceutica N.V. 1-Benzazolylalkyl-4-substituted-piperidines

Also Published As

Publication number Publication date
KR850002015A (ko) 1985-04-10
SU1041034A3 (ru) 1983-09-07
MY8700555A (en) 1987-12-31
ATE5258T1 (de) 1983-11-15
NO800034L (no) 1980-07-09
PL125789B1 (en) 1983-06-30
IL59084A (en) 1984-02-29
KR850000683B1 (ko) 1985-05-14
HK76284A (en) 1984-10-19
DK170669B1 (da) 1995-11-27
NZ192551A (en) 1984-07-06
CY1252A (en) 1984-08-31
ES487537A0 (es) 1980-12-16
PT70662A (en) 1980-02-01
FI66609B (fi) 1984-07-31
DK7280A (da) 1980-07-09
NO155243B (no) 1986-11-24
IL59084A0 (en) 1980-05-30
JPS55105679A (en) 1980-08-13
KR830001926A (ko) 1983-05-19
IE49351B1 (en) 1985-09-18
AU536175B2 (en) 1984-04-19
FI800047A (fi) 1980-07-09
AU5438180A (en) 1980-07-17
FI66609C (fi) 1984-11-12
EP0013612B1 (fr) 1983-11-09
LU88219I2 (fr) 1994-02-03
US4335127A (en) 1982-06-15
KR850000684B1 (ko) 1985-05-14
SG48684G (en) 1985-03-29
YU4680A (en) 1983-06-30
RO79148A (fr) 1982-08-17
IE800021L (en) 1980-07-08
EP0013612A3 (en) 1980-10-15
NO155243C (no) 1987-03-04
YU42957B (en) 1989-02-28
CS223977B2 (en) 1983-11-25
ES8101586A1 (es) 1980-12-16
NL930018I1 (nl) 1993-05-03
PL221249A1 (fr) 1980-12-01
HU184222B (en) 1984-07-30
KR850000677B1 (ko) 1985-05-10
NL930018I2 (nl) 1993-09-16
ZA8082B (en) 1981-08-26
CA1132557A (fr) 1982-09-28
EP0013612A2 (fr) 1980-07-23
PH17114A (en) 1984-06-01
GR67304B (fr) 1981-06-29
JPS6346753B2 (fr) 1988-09-19
DE3065489D1 (en) 1983-12-15

Similar Documents

Publication Publication Date Title
MA18694A1 (fr) Nouveaux derives de piperidinyl alkyl-quinazoline
NO983970L (no) Tricykliske forbindelser, deres fremstilling og anvendelse
ES8504723A1 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolonas.
ATE247660T1 (de) Furopyridinderivate und ihre therapeutische verwendung
DK415789D0 (da) Tetracykliske antidepressive midler
KR870004038A (ko) 제초제 화합물의 제조방법
WO2000008020A3 (fr) Nouveaux composes
ATE17490T1 (de) Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.